
Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (26)
- Biology and Soft Matter (1)
- Computational Biology (2)
- Computational Engineering (1)
- Energy Science (18)
- Fusion and Fission (5)
- Isotopes (6)
- Materials (37)
- Materials for Computing (6)
- National Security (3)
- Neutron Science (16)
- Nuclear Science and Technology (2)
- Supercomputing (21)
News Topics
- (-) Biomedical (73)
- (-) Chemical Sciences (84)
- 3-D Printing/Advanced Manufacturing (144)
- Advanced Reactors (40)
- Artificial Intelligence (125)
- Big Data (77)
- Bioenergy (110)
- Biology (126)
- Biotechnology (37)
- Buildings (73)
- Clean Water (32)
- Composites (34)
- Computer Science (223)
- Coronavirus (48)
- Critical Materials (29)
- Cybersecurity (35)
- Education (5)
- Element Discovery (1)
- Emergency (4)
- Energy Storage (114)
- Environment (217)
- Exascale Computing (64)
- Fossil Energy (8)
- Frontier (62)
- Fusion (65)
- Grid (74)
- High-Performance Computing (128)
- Hydropower (12)
- Irradiation (3)
- Isotopes (62)
- ITER (9)
- Machine Learning (67)
- Materials (156)
- Materials Science (156)
- Mathematics (12)
- Mercury (12)
- Microelectronics (4)
- Microscopy (56)
- Molten Salt (10)
- Nanotechnology (63)
- National Security (86)
- Neutron Science (169)
- Nuclear Energy (121)
- Partnerships (66)
- Physics (68)
- Polymers (35)
- Quantum Computing (52)
- Quantum Science (88)
- Security (30)
- Simulation (64)
- Software (1)
- Space Exploration (26)
- Statistics (4)
- Summit (70)
- Transportation (102)
Media Contacts

ORNL researchers created and tested two methods for transforming coal into the scarce mineral graphite, which is used in batteries for electric vehicles.

A chemical reaction can convert two polluting greenhouse gases into valuable building blocks for cleaner fuels and feedstocks, but the high temperature required for the reaction also deactivates the catalyst. A team led by ORNL has found a way to thwart deactivation. The strategy may apply broadly to other catalysts.
Seven scientists affiliated with ORNL have been named Battelle Distinguished Inventors in recognition of being granted 14 or more United States patents. Since Battelle began managing ORNL in 2000, 104 ORNL researchers have reached this milestone.

Using a best-of-nature approach developed by researchers working with the Center for Bioenergy Innovation at the Department of Energy’s Oak Ridge National Laboratory and Dartmouth University, startup company Terragia Biofuel is targeting commercial biofuels production that relies on renewable plant waste and consumes less energy. The technology can help meet the demand for billions of gallons of clean liquid fuels needed to reduce emissions from airplanes, ships and long-haul trucks.

Researchers have identified a molecule essential for the microbial conversion of inorganic mercury into the neurotoxin methylmercury, moving closer to blocking the dangerous pollutant before it forms.

Researchers used the world’s fastest supercomputer, Frontier, to train an AI model that designs proteins, with applications in fields like vaccines, cancer treatments, and environmental bioremediation. The study earned a finalist nomination for the Gordon Bell Prize, recognizing innovation in high-performance computing for science.
Verónica Melesse Vergara and Felipe Polo-Garzon, two staff members at ORNL have been honored with Luminary Awards from Great Minds in STEM, a nonprofit organization dedicated to promoting STEM careers in underserved communities.

A team of researchers used the Frontier supercomputer and a new methodology for conducting a genome-wide association study to earn a finalist nomination for the Association for Computing Machinery’s 2024 Gordon Bell Prize for outstanding

Biochemist David Baker — just announced as a recipient of the Nobel Prize for Chemistry — turned to the High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory for information he couldn’t get anywhere else. HFIR is the strongest reactor-based neutron source in the United States.

Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses.